Categories: AdTechDevelopmentHardwareHealthTechLifeMedtechProductTools
Lymphatica Medtech is pioneering advancements in lymphedema treatment with its flagship product, LymphoDrain—a minimally invasive, implantable device designed to restore lymphatic function. By actively replacing the draining function of lymphatic vessels, LymphoDrain aims to significantly improve the quality of life for patients suffering from this chronic condition.Lymphatica Medtech’s mission is to become a leader in developing and marketing innovative medical devices for the treatment of lymphatic diseases, offering effective solutions that integrate seamlessly into patients’ lives.
Investors 2
Mentions in press and media 6
| Date | Title | Description |
| 12.07.2024 | Industry experts avail resources to young companies |
From the Top 10 selected startups for the Swiss Prime Site Accelerator Program, VAULTED AG, viboo and Resilientsy emerged as finalists, winning a ticked for an intensive Acceleration Programme. They would collaborate with Swiss Prime Site ... |
| 12.02.2024 | Lymphatica Medtech awarded FDA Breakthrough Device Designation |
Chronic lymphedema, characterized by debilitating swelling of limbs, poses a considerable challenge for millions worldwide, particularly those who have undergone cancer treatment involving lymph node removal or damage. LymphoDrain, an inno... |
| 24.10.2023 | Startups appoint industry mavens to their board of directors | |
| 15.06.2023 | CHF 1.2M FIT Funding for Imverse, Isochronic & Lymphatica | Merging the real world and holograms
Imverse revolutionizes hologram broadcasting with its cutting-edge technology. Based in Morges, this pioneering EPFL spin-off enables users to instantly broadcast their own live holograms. The technology... |
| 28.04.2023 | Swiss Accelerator: Innosuisse supports 53 companies with CHF112 million | |
| 30.03.2023 | 15 startups contest to win CHF 100,000 | |
Reviews 0
